The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 18384710)

Published in Curr Med Res Opin on April 01, 2008

Authors

Craig I Coleman, Kurt Reinhart, Jeffrey Kluger, C Michael White

Articles citing this

Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol (2010) 2.18

Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation. Am J Cardiol (2011) 1.60

Are statins diabetogenic? Curr Opin Cardiol (2011) 1.54

Statins and risk of treated incident diabetes in a primary care population. Br J Clin Pharmacol (2013) 1.18

Statins and the risk of type 2 diabetes mellitus: cohort study using the UK clinical practice pesearch datalink. BMC Cardiovasc Disord (2014) 1.10

Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention? Cardiovasc Diabetol (2012) 0.98

Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe? Nutr Metab (Lond) (2009) 0.87

Differential metabolic actions of specific statins: clinical and therapeutic considerations. Antioxid Redox Signal (2013) 0.83

Statin induced diabetes and its clinical implications. J Pharmacol Pharmacother (2014) 0.83

Combination pravastatin and valsartan treatment has additive beneficial effects to simultaneously improve both metabolic and cardiovascular phenotypes beyond that of monotherapy with either drug in patients with primary hypercholesterolemia. Diabetes (2013) 0.82

Statin Use Is Associated With Incident Diabetes Mellitus Among Patients in the HIV Outpatient Study. J Acquir Immune Defic Syndr (2015) 0.80

Rosuvastatin and atorvastatin: comparative effects on glucose metabolism in non-diabetic patients with dyslipidaemia. Clin Med Insights Endocrinol Diabetes (2012) 0.79

Risk of new-onset diabetes associated with statin use. SAGE Open Med (2015) 0.78

The diabetogenic action of statins - mechanisms and clinical implications. Nat Rev Endocrinol (2015) 0.77

Role of bile acid sequestrants in the treatment of type 2 diabetes. World J Diabetes (2010) 0.77

Statin-induced diabetes: will it change clinical practice? Diabetes Care (2009) 0.77

Different effects of statins on induction of diabetes mellitus: an experimental study. Drug Des Devel Ther (2015) 0.76

Colesevelam hydrochloride: evidence for its use in the treatment of hypercholesterolemia and type 2 diabetes mellitus with insights into mechanism of action. Core Evid (2012) 0.76

Do statins really cause diabetes? A meta-analysis of major randomized controlled clinical trials. Saudi Med J (2016) 0.75

Rosuvastatin does not affect fasting glucose, insulin resistance, or adiponectin in patients with mild to moderate hypertension. Chonnam Med J (2013) 0.75

Atorvastatin but Not Pravastatin Impairs Mitochondrial Function in Human Pancreatic Islets and Rat β-Cells. Direct Effect of Oxidative Stress. Sci Rep (2017) 0.75

Articles by these authors

Statins and cancer risk: a meta-analysis. JAMA (2006) 6.28

Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA (2010) 4.45

Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA (2004) 2.86

Effect of statins on skeletal muscle function. Circulation (2012) 2.54

Number and impact of published scholarly works by pharmacy practice faculty members at accredited US colleges and schools of pharmacy (2001-2003). Am J Pharm Educ (2007) 2.36

Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med (2011) 2.28

Impact of statin dosing intensity on transaminase and creatine kinase. Am J Med (2007) 2.15

Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm (2009) 2.08

Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care (2008) 1.91

Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis (2007) 1.87

Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation. Am J Cardiol (2012) 1.79

Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis. Chest (2015) 1.70

Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol (2003) 1.65

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Ann Intern Med (2009) 1.62

Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation (2005) 1.56

The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis. J Clin Psychiatry (2010) 1.56

Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg (2008) 1.55

Effect of intravenous testosterone on myocardial ischemia in men with coronary artery disease. Am Heart J (2002) 1.49

Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation. Europace (2009) 1.45

Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials. J Am Diet Assoc (2009) 1.44

A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg (2002) 1.43

Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol (2003) 1.42

Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis. Diabetes Res Clin Pract (2009) 1.42

Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction. Heart Rhythm (2007) 1.42

The renal protective effects of angiotensin II receptor blockers in type 2 diabetes mellitus. Ann Pharmacother (2004) 1.41

Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. Ann Fam Med (2008) 1.41

Prasugrel: a critical comparison with clopidogrel. Pharmacotherapy (2009) 1.41

Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review. Int J Clin Pract (2011) 1.41

Therapeutic hypothermia is associated with improved neurologic outcome and survival in cardiac arrest survivors of non-shockable rhythms. Resuscitation (2011) 1.41

Fortuitous therapeutic effect of Taser shock for a patient in atrial fibrillation. Ann Emerg Med (2008) 1.39

Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Ann Pharmacother (2007) 1.38

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients. Curr Med Res Opin (2014) 1.36

Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J Hypertens (2008) 1.35

Understanding heterogeneity in meta-analysis: the role of meta-regression. Int J Clin Pract (2009) 1.34

The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care (2005) 1.22

A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design. Prev Cardiol (2010) 1.21

Effect of cinnamon on glucose control and lipid parameters. Diabetes Care (2007) 1.17

Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr (2009) 1.16

The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med (2009) 1.15

Postoperative atrial fibrillation - what do we really know? Curr Vasc Pharmacol (2010) 1.14

Oral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta-analysis. Ann Pharmacother (2012) 1.11

Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract (2010) 1.11

Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin (2007) 1.09

Efficacy of statins in combination with interferon therapy in multiple sclerosis: a meta-analysis. Am J Health Syst Pharm (2012) 1.07

Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis. BMC Fam Pract (2012) 1.07

Staying healthy. A public mess. Time (2002) 1.06

Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes. Am J Cardiovasc Drugs (2009) 1.06

The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail (2006) 1.02

Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med (2013) 1.02

The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg. Atherosclerosis (2008) 1.01

Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Pharmacotherapy (2009) 1.01

Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother (2008) 1.00

Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillation. PLoS One (2012) 0.99

Effect of topiramate on weight gain in patients receiving atypical antipsychotic agents. J Clin Psychopharmacol (2013) 0.98

Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc (2011) 0.98

Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet (2002) 0.98

Moxifloxacin and torsade de pointes. Ann Pharmacother (2007) 0.98

The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc (2011) 0.98

Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. Am J Clin Nutr (2008) 0.97

Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation (2003) 0.97

Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg (2007) 0.97

Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review. Pharmacotherapy (2012) 0.96

Electromagnetic Interference (EMI) and arrhythmic events in ICD patients undergoing gastrointestinal procedures. Pacing Clin Electrophysiol (2007) 0.95

Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging (2012) 0.95

Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Clin Ther (2008) 0.95

Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review. BMJ Open (2013) 0.94

Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother (2002) 0.94